SV119-gold nanocage conjugates: a new platform for targeting cancer cells via sigma-2 receptors
about
Research perspectives: gold nanoparticles in cancer theranosticsThe σ2 receptor: a novel protein for the imaging and treatment of cancer.Using SV119-gold nanocage conjugates to eradicate cancer stem cells through a combination of photothermal and chemo therapies.Sigma-2 receptor ligands and their perspectives in cancer diagnosis and therapy.Cytophilic/cytophobic design of nanomaterials at biointerfaces.Characterization of spherulites as a lipidic carrier for low and high molecular weight agentsSigma receptors [σRs]: biology in normal and diseased statesUltrabright fluorescent mesoporous silica nanoparticles for prescreening of cervical cancerEmerging advances in nanomedicine with engineered gold nanostructures.Review peptide-targeted liposomes for selective drug delivery: Advantages and problematic issues.A bioresponsive controlled-release bioassay based on aptamer-gated Au nanocages and its application in living cells.The Evolution of the Sigma-2 (σ2) Receptor from Obscure Binding Site to Bona Fide Therapeutic Target.Nanocaged platforms: modification, drug delivery and nanotoxicity. Opening synthetic cages to release the tiger.A bioresponsive controlled-release biosensor using Au nanocages capped with an aptamer-based molecular gate and its application in living cells.Incorporation of a selective sigma-2 receptor ligand enhances uptake of liposomes by multiple cancer cells.Isothermal amplified detection of ATP using Au nanocages capped with a DNA molecular gate and its application in cell lysates.
P2860
Q30444675-43A4EC00-641F-444C-8ED6-EEF67B53E56EQ33782364-5D6BC7F1-2ADE-422E-8C13-F32F5971211BQ34052669-8285A0A3-8907-41B9-BC80-926A8DD56AFEQ34362333-A0E22838-8084-414B-A107-9D822377FF8AQ34589395-9B6EE0D1-8F93-4CEE-98D5-537BD094C250Q34665722-C62F4556-A35A-443E-837E-CEE80FAC13C0Q37000551-98C0C9B8-E84C-42A8-AEF1-66188DFB737BQ37275052-8DA4563B-B839-4400-936B-8464ED339B97Q38180306-61D9A3BC-6313-4DEB-9765-4BCAD07EB07CQ38502588-7EF82FC6-18B0-4D2F-823F-3C8AA0A32AA4Q38879259-31829F3A-A1CE-4211-944D-F9802C291C34Q38896673-4699EC1B-ECBD-41D5-B3D4-50C415ED3AD6Q39076542-87E26BDD-3054-4A45-A89F-31797AE79B50Q39280985-EECF1EA4-2687-4B0F-AA56-9AB113D6BE2DQ39289664-DA6FBC82-89FF-4601-917C-EED62A0333F5Q53327864-A33BADCF-62DB-449C-9F8C-EFE599EA83F7
P2860
SV119-gold nanocage conjugates: a new platform for targeting cancer cells via sigma-2 receptors
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
SV119-gold nanocage conjugates ...... er cells via sigma-2 receptors
@en
SV119-gold nanocage conjugates ...... r cells via sigma-2 receptors.
@nl
type
label
SV119-gold nanocage conjugates ...... er cells via sigma-2 receptors
@en
SV119-gold nanocage conjugates ...... r cells via sigma-2 receptors.
@nl
prefLabel
SV119-gold nanocage conjugates ...... er cells via sigma-2 receptors
@en
SV119-gold nanocage conjugates ...... r cells via sigma-2 receptors.
@nl
P2093
P2860
P50
P356
P1433
P1476
SV119-gold nanocage conjugates ...... er cells via sigma-2 receptors
@en
P2093
Miaoxin Yang
Robert H Mach
Suwanna Vangveravong
Younan Xia
P2860
P304
P356
10.1039/C1NR11469G
P407
P577
2011-11-24T00:00:00Z